trial · primary record
Spironolactone
Pulmonary Arterial Hypertension
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 70 |
| Primary completion | 2031-12-31 |
| Primary endpoint | Change in placebo corrected 6-minute walk distance |
| Registry ID | NCT01712620 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:12.755Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT01712620
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- SPIRONOLACTONE · approval
- Spironolactone · compound